Paradromics and Neuralink are leading the race in developing advanced brain implants. Reports highlight differences in ...

Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Telco extends presence in API arena with two products designed to give businesses practical tools to improve customer experience, while laying the foundation for models of innovation and collaboration ...

The Gemini API improvements include simpler controls over thinking, more granular control over multimodal vision processing, ...

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...

Powerful artificial intelligence (AI) systems, like ChatGPT and Gemini, simulate understanding of comedy wordplay, but never really "get the joke," a new study suggests.

Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

The ability of these devices to access aspects of a person’s innermost life, including preconscious thought, raises the ...

FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...

There has been a lot of discussion across the channel for the need for customers to start the journey to artificial intelligence (AI) by focusing on the data foundations. That challenge is not just a ...